Oncocyte To Announce First Quarter 2023 Financial Results
27 avr. 2023 16h59 HE
|
Oncocyte Corporation
IRVINE, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, announced today that it will release its first quarter 2023 financial...
Oncocyte Presents New Data at AACR
18 avr. 2023 08h45 HE
|
Oncocyte Corporation
IRVINE, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that five posters of original research are being presented at...
Oncocyte Announces Reduction in Force
12 avr. 2023 16h15 HE
|
Oncocyte Corporation
IRVINE, Calif., April 12, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced a reduction in force involving approximately 20% of its...
Oncocyte Announces Publication of DetermaIO Results from AtezoTRIBE Study in Metastatic Colorectal Cancer
07 avr. 2023 08h24 HE
|
Oncocyte Corporation
IRVINE, Calif., April 07, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostic company, today announces the peer-reviewed publication of the results of a study...
Oncocyte Pricing of $13.86 Million Public Offering of Common Stock
03 avr. 2023 08h00 HE
|
Oncocyte Corporation
IRVINE, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), (“Oncocyte” or the “Company”), a precision diagnostics company, announced today the entry into an agreement...
Oncocyte Reports Preliminary Fourth Quarter and Full Year 2022 Financial Results and Plans to File Form 12b-25 to Extend Filing Date of Its Form 10-K
31 mars 2023 17h00 HE
|
Oncocyte Corporation
IRVINE, Calif., March 31, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced plans to file a Form 12b-25 with the U.S. Securities and...
Oncocyte Announces Date Change for Fourth Quarter and Full Year 2022 Earnings Call
29 mars 2023 16h01 HE
|
Oncocyte Corporation
IRVINE, Calif., March 29, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, announced today that it has changed the date of its previously announced...
Oncocyte to Announce Fourth Quarter and Full Year 2022 Financial Results
15 mars 2023 16h01 HE
|
Oncocyte Corporation
IRVINE, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, announced today that it will release its fourth quarter and full year 2022...
Oncocyte Appoints Joshua Riggs as President and Chief Executive Officer
02 mars 2023 09h00 HE
|
Oncocyte Corporation
IRVINE, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that Joshua Riggs has been appointed as its Chief Executive...
Oncocyte Completes Razor Genomics Transaction
22 févr. 2023 08h00 HE
|
Oncocyte Corporation
Company retains 30% stake while eliminating operating expense and future development obligations Represents next step in plan to focus product strategy IRVINE, Calif., Feb. 22, 2023 (GLOBE...